TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IMRX

Immuneering Corp

Healthcare · Biotechnology

4.50$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IMRX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
63.7% 55.4% 55.4% 49.9% 167,942.4%
36.3% 44.6% 44.6% 50.1% -167,942.4%
222.9% 649.1% 1,276.0% 11,442.5% 9,148,135.8%
141.1% 134.5% 397.7% 4,924.1% 3,683,516.5%
364.0% 783.6% 1,673.7% 16,375.9% 12,837,997.1%
-327.7% -739.0% -1,629.2% -16,325.8% -12,837,997.1%
18.3% 1.8% 9.7% 320.1%
-401.6% -740.8% -1,627.1% -15,937.4% -11,752,092.3%
18.3% -3.6% -14.8% -388.6% 0.4%
-401.6% -737.2% -1,612.3% -15,937.3% -11,752,004.8%
-382.4% -735.6% -1,621.5% -16,238.4% -12,760,703.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?